2013 July


1. Plasma acetylcholinesterase activity correlates with intracerebral β-amyloid load. Curr Alzheimer Res. 2013 Jan;10(1):48-56.

Hermona Soreq-2

3. Protective role of clusterin in preserving endothelial function in AL amyloidosis. Atherosclerosis. 2012 Nov;225(1):220-3.

Heather Kenna DMN Supplemental Figure 14. Fasting plasma insulin and the default mode network in women at risk for Alzheimer’s disease. Neurobiol Aging. 2013 Mar;34(3):641-9.

7. Emerging approaches for treatment of schizophrenia: modulation of cholinergic signaling. Discov Med. 2012 Dec;14(79):413-20.

9. Brain regional correlation of amyloid-β with synapses and apolipoprotein E in non-demented individuals: potential mechanisms underlying regional vulnerability to amyloid-β accumulation. Acta Neuropathol. 2013 Apr;125(4):535-47.

11. Elusive Alzheimer’s disease: can immune signatures help our understanding of this challenging disease? Part 1: clinical and historical background. Discov Med. 2013 Jan;15(80):23-32. Part 2: new immune paradigm. Discov Med. 2013 Jan;15(80):33-42.

13-2. GRN variant rs5848 reduces plasma and brain levels of granulin in Alzheimer’s disease patients. J Alzheimers Dis. 2013;33(1):23-7.

16. Angiotensin-receptor blockers and risk of Alzheimer’s disease in hypertension population–a nationwide cohort study. Circ J. 2013;77(2):405-10.

Cláudia Pereira-png219. Endoplasmic reticulum stress occurs downstream of GluN2B subunit of N-methyl-d-aspartate receptor in mature hippocampal cultures treated with amyloid-β oligomers. Aging Cell. 2012 Oct;11(5):823-33.




2. β-Amyloid in Lewy body disease is related to Alzheimer’s disease-like atrophy. Mov Disord. 2013 Feb;28(2):169-75.

Sanchez-Ramos Juan-25. Pilot study of granulocyte-colony stimulating factor for treatment of Alzheimer’s disease. J Alzheimers Dis. 2012;31(4):843-55.

Marie-Gibbs jpg6. Deleterious effects of soluble beta amyloid on cognition, antagonism by saline and noradrenaline, a role for microglia. Neuroscience. 2013 Jan 29;230:62-71.


8. Role of platelets in neurodegenerative diseases: a universal pathophysiology. Int J Neurosci. 2013 May;123(5):287-99.

10. Tracking pathophysiological processes in Alzheimer’s disease: an updated hypothetical model of dynamic biomarkers. Lancet Neurol. 2013 Feb;12(2):207-16.

12. SpeedyRINGO inhibits calpain-directed apoptosis in neurons. J Alzheimers Dis.2012 31(4):779-791).

13. Integration of genome-wide expression and methylation data: relevance to aging and Alzheimer’s disease. Neurotoxicology. 2012 Dec;33(6):1450-3.

14. COST: Cognitive State Test, a brief screening battery for Alzheimer disease in illiterate and literate patients. Int Psychogeriatr. 2013 Mar;25(3):403-12.

15. Structural heterogeneity in familial Alzheimer’s disease mutants of amyloid-beta peptides. Mol Biosyst. 2013 May;9(5):997-1003.

17. Keap1 is localized in neuronal and glial cytoplasmic inclusions in various neurodegenerative diseases. J Neuropathol Exp Neurol. 2013 Jan;72(1):18-28.

18. Identification of polypeptides in neurofibrillary tangles and total homogenates of brains with Alzheimer’s disease by tandem mass spectrometry. J Alzheimers Dis. 2013 Jan 1;34(1):239-62.

20. Sex and gender differences in Alzheimer’s disease: recommendations for future research. J Womens Health (Larchmt). 2012 Oct;21(10):1018-23.


Multiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier SchönmannMultiselect Ultimate Query Plugin by InoPlugs Web Design Vienna | Webdesign Wien and Juwelier Schönmann